We are live on ! Find out more
NVAX icon

Novavax

89 hedge funds and large institutions have $142M invested in Novavax in 2013 Q2 according to their latest regulatory filings, with 89 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less call options, than puts

Call options by funds: $429K | Put options by funds: $454K

Holders
89
Holders Change
+89
Holders Change %
% of All Funds
2.9%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
89
Increased
Reduced
Closed
Calls
$429K
Puts
$454K
Net Calls
-$25K
Net Calls Change
-$25K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NVAX Hedge Fund Activity: Q2 2013 in Review

89 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2013, worth a combined $142M.

Buyers outnumbered sellers: 89 funds opened new NVAX positions and 0 closed out — a net gain of 89 holders — while 0 added to existing stakes and 0 trimmed.

  • 89 institutional investors held Novavax (NVAX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $142M of Novavax stock for Q2 2013.
  • 89 funds opened new Novavax positions in Q2 2013 and 0 closed out, a net change of +89 holders.

Based on aggregated 13F filings for Q2 2013.